These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10497225)

  • 1. Transcriptional state of the mouse mammary tumor virus promoter can affect topological domain size in vivo.
    Kramer PR; Fragoso G; Pennie W; Htun H; Hager GL; Sinden RR
    J Biol Chem; 1999 Oct; 274(40):28590-7. PubMed ID: 10497225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of unrestrained negative supercoiling and topological domain size in living human cells.
    Kramer PR; Sinden RR
    Biochemistry; 1997 Mar; 36(11):3151-8. PubMed ID: 9115991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional elements of the steroid hormone-responsive promoter of mouse mammary tumor virus.
    Toohey MG; Lee JW; Huang M; Peterson DO
    J Virol; 1990 Sep; 64(9):4477-88. PubMed ID: 2166825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the TATA box in transcription of the mouse mammary tumor virus long terminal repeat.
    Kusk P; Carlson KE; Warren BS; Hager GL
    Mol Endocrinol; 1995 Sep; 9(9):1180-92. PubMed ID: 7491110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of the glucocorticoid regulatory elements present in the mouse mammary tumor virus long terminal repeat. A synthetic distal binding site can replace the proximal binding domain.
    Kühnel B; Buetti E; Diggelmann H
    J Mol Biol; 1986 Aug; 190(3):367-78. PubMed ID: 3023640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of higher-order secondary and tertiary chromatin structures by genomic mouse mammary tumor virus promoters.
    Georgel PT; Fletcher TM; Hager GL; Hansen JC
    Genes Dev; 2003 Jul; 17(13):1617-29. PubMed ID: 12842912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat.
    Vacca A; Screpanti I; Maroder M; Petrangeli E; Frati L; Gulino A
    Mol Endocrinol; 1989 Oct; 3(10):1659-65. PubMed ID: 2558300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo.
    Cordingley MG; Riegel AT; Hager GL
    Cell; 1987 Jan; 48(2):261-70. PubMed ID: 3026639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal position effects determine transcriptional potential of integrated mammary tumor virus DNA.
    Feinstein SC; Ross SR; Yamamoto KR
    J Mol Biol; 1982 Apr; 156(3):549-65. PubMed ID: 6288960
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient and dynamic DNA supercoiling potently stimulates the
    Zhi X; Dages S; Dages K; Liu Y; Hua ZC; Makemson J; Leng F
    J Biol Chem; 2017 Sep; 292(35):14566-14575. PubMed ID: 28696257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
    Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
    J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of dexamethasone 21-mesylate antiglucocorticoid action: II. Receptor-antiglucocorticoid complexes do not interact productively with mouse mammary tumor virus long terminal repeat chromatin.
    Richard-Foy H; Sistare FD; Riegel AT; Simons SS; Hager GL
    Mol Endocrinol; 1987 Sep; 1(9):659-65. PubMed ID: 2856414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of DNA structure in vivo using psoralen photobinding: measurement of supercoiling, topological domains, and DNA-protein interactions.
    Sinden RR; Ussery DW
    Methods Enzymol; 1992; 212():319-35. PubMed ID: 1518453
    [No Abstract]   [Full Text] [Related]  

  • 15. Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter.
    Gouilleux F; Sola B; Couette B; Richard-Foy H
    Nucleic Acids Res; 1991 Apr; 19(7):1563-9. PubMed ID: 1851294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale effects of transcriptional DNA supercoiling in vivo.
    Krasilnikov AS; Podtelezhnikov A; Vologodskii A; Mirkin SM
    J Mol Biol; 1999 Oct; 292(5):1149-60. PubMed ID: 10512709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo.
    Mymryk JS; Zaniewski E; Archer TK
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2076-80. PubMed ID: 7892227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary tumor virus DNA: a glucocorticoid-responsive transposable element.
    Yamamoto KR; Stallcup MR; Ring J; Ringold GM
    Cold Spring Harb Symp Quant Biol; 1978; 42 Pt 2():625-38. PubMed ID: 28200
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter.
    Archer TK; Lee HL; Cordingley MG; Mymryk JS; Fragoso G; Berard DS; Hager GL
    Mol Endocrinol; 1994 May; 8(5):568-76. PubMed ID: 8058066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
    Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
    Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.